Enara Bio
Enara Bio is a science-led company targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies designed to treat a broad patient population. Enara Bio focuses on discovering and developing therapeutic cancer vaccines utilizing novel antigens derived from endogenous retroviral (ERV)-related DNA sequences.
Domain
enarabio.com
Country
United KingdomIndustry
BiotechnologyEmployees
51-100
Last Funding
$32.5M
Founded
2015
Tech Stack (8 technologies)
Frequently Asked Questions
What technologies does Enara Bio use?+
Enara Bio uses 8 technologies including Google Analytics, Google Tag Manager, Webpack.
What industry is Enara Bio in?+
Enara Bio operates in the Biotechnology industry.
Where is Enara Bio based?+
Enara Bio is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026